Recent insider trading activity from Sands Capital Life Sciences Pulse Fund II, L.P., including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Sands Capital Life Sciences Pulse Fund II, L.P. | TenPercentOwner | P | Common Stock | 2068965 | $1.45 | 13,018,965.0000 | 90,050,973 | 18.89% | 2.30% |